Antengene Corporation Ltd
HKEX:6996
Antengene Corporation Ltd
Total Assets
Antengene Corporation Ltd
Total Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Antengene Corporation Ltd
HKEX:6996
|
Total Assets
¥1.3B
|
CAGR 3-Years
-19%
|
CAGR 5-Years
12%
|
CAGR 10-Years
N/A
|
|
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Total Assets
¥31.7B
|
CAGR 3-Years
5%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
|
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Total Assets
¥18B
|
CAGR 3-Years
15%
|
CAGR 5-Years
16%
|
CAGR 10-Years
18%
|
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Total Assets
¥50.1B
|
CAGR 3-Years
8%
|
CAGR 5-Years
13%
|
CAGR 10-Years
19%
|
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Total Assets
¥52.9B
|
CAGR 3-Years
0%
|
CAGR 5-Years
1%
|
CAGR 10-Years
12%
|
|
|
C
|
CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
|
Total Assets
¥5.7B
|
CAGR 3-Years
22%
|
CAGR 5-Years
16%
|
CAGR 10-Years
N/A
|
|
Antengene Corporation Ltd
Glance View
Antengene Corp. Ltd. operates as clinical-stage Asia-Pacific biopharmaceutical company. The company is headquartered in Shanghai, Shanghai. The company went IPO on 2020-11-20. The firm is principally engaged in the discovery, development, manufacturing and commercialization of biotech products. The Company’s products include ATG-010 (selinexor), treating for relapsed/refractory multiple myeloma, relapsed/refractory diffuse large B-cell lymphoma and non-small cell lung cancer and ATG-008 (onatasertib), treating for hepatocellular carcinoma and non-small cell lung cancer. The firm mainly conducts its business in Asia-Pacific.
See Also
What is Antengene Corporation Ltd's Total Assets?
Total Assets
1.3B
CNY
Based on the financial report for Dec 31, 2024, Antengene Corporation Ltd's Total Assets amounts to 1.3B CNY.
What is Antengene Corporation Ltd's Total Assets growth rate?
Total Assets CAGR 5Y
12%
Over the last year, the Total Assets growth was -17%. The average annual Total Assets growth rates for Antengene Corporation Ltd have been -19% over the past three years , 12% over the past five years .
You don't have any saved screeners yet